Medindia

X

Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.

by Savitha C Muppala on  December 23, 2012 at 11:39 PM Drug News   - G J E 4
Gattex (teduglutide) has received the approval by the U.S. Food and Drug Administration as a good form of treatment for nutritional problems caused by short bowel syndrome, which occurs after the small and/or large intestine is surgically removed.
 Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.
Gattex, a New Medicine for Short Bowel Syndrome Has Been Approved by the FDA.
Advertisement

This injection is used to help improve intestinal absorption and is administered once a day. Somatropin and glutamine, two other drugs used to treat short bowel disorder have also been approved by the FDA.

Advertisement
Nausea, headache, abdominal pain and upper respiratory tract infection could be some of the common side effects. This drug was evaluated in two clinical studies and two extension studies.

This medicine provides nutrition for people whose intestines have been surgically removed since extensive removal of the intestines leads to poor absorption of liquids.

.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All